$1.39
0[0.00%]
Last update: 7:44PM Get Real Time Here
Avrobio
(NASDAQ:AVRO)Latest News for Avrobio Stock (NASDAQ:AVRO)
Avrobio Stock (NASDAQ: AVRO)
Categories: All
Tuesday, January 30, 2024
- AVROBIO shares are trading lower after the company announced it will acquire 100% of the outstanding equity interests of Tectonic Therapeutic.Benzinga Newsdesk - Jan 30, 2024, 9:29AM
- Trading Halt: Halt status updated at 8:25:00 AM ET: Quotation Resumption: News and Resumption TimesBenzinga Newsdesk - Jan 30, 2024, 8:25AM
- AVROBIO And Tectonic Therapeutic Announce Merger In All-Stock Transaction; AVROBIO To Acquire 100% Of Outstanding Equity Interests Of TectonicBenzinga Newsdesk - Jan 30, 2024, 8:04AM
- Trading Halt: Halted at 7:55:00 a.m. ET - Trading Halt: Halt News PendingBenzinga Newsdesk - Jan 30, 2024, 7:55AM
Monday, December 18, 2023
Thursday, July 13, 2023
Wednesday, July 12, 2023
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Jul 12, 2023, 1:37PM
- Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Jul 12, 2023, 12:53PM
- Wedbush Downgrades Avrobio to Neutral, Announces $2 Price TargetBenzinga Newsdesk - Jul 12, 2023, 11:40AM
- Why Avrobio Shares Are Rising WednesdayAdam Eckert - Jul 12, 2023, 11:02AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Jul 12, 2023, 9:12AM
- Market-Moving News for July 12thBenzinga Newsdesk - Jul 12, 2023, 8:34AM
- Avrobio shares are trading higher after the company announced to explore strategic alternatives.Benzinga Newsdesk - Jul 12, 2023, 8:18AM
- AVROBIO Shares Shares To Resume Trade At 7:30 AM ETCharles Gross - Jul 12, 2023, 7:11AM
- Avrobio Will Halt Further Development Of Its Programs And Conduct A Comprehensive Exploration Of Strategic AlternativesBenzinga Newsdesk - Jul 12, 2023, 7:11AM
- Avrobio Shares Halted; Pending NewsCharles Gross - Jul 12, 2023, 6:56AM
Wednesday, June 07, 2023
Monday, May 22, 2023
- Avrobio Stock Jumps On Sale Of Gene Therapy Program To NovartisRyan Gustafson - May 22, 2023, 3:58PM
- Dow Tumbles 100 Points; Micron Technology Shares PlungeLisa Levin - May 22, 2023, 2:30PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - May 22, 2023, 1:31PM
- Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - May 22, 2023, 1:20PM
- Avrobio Offloads Gene Therapy Program For Rare Genetic Disorder To NovartisVandana Singh - May 22, 2023, 1:04PM
- Nasdaq Rises Over 50 Points; Greenhill Shares Spike HigherLisa Levin - May 22, 2023, 12:07PM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - May 22, 2023, 9:06AM
- Avrobio shares are trading higher after the company announced it would sell its gene therapy program to Novartis for $87.5M.Benzinga Newsdesk - May 22, 2023, 8:09AM
- AVROBIO Agrees To Sell Cystinosis Gene Therapy Program To Novartis For $87.5MBenzinga Newsdesk - May 22, 2023, 7:06AM
Thursday, May 18, 2023
- Analyst Says Gene Therapy Data Update Offers Insights into Potential Pivotal EndpointsVandana Singh - May 18, 2023, 2:32PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - May 18, 2023, 1:31PM
- Avrobio Touts Positive Data Gene Therapy Trial For Cystinosis, Showing Treatment Durability Of Up To 36 MonthsVandana Singh - May 18, 2023, 12:53PM
- AVROBIO shares are trading higher after the company announced data from the Phase 1/2 clinical trial of an investigational gene therapy for cystinosis.Benzinga Newsdesk - May 18, 2023, 11:11AM
- Avrobio Announced Follow-up Data Demonstrating A Durable Treatment Effect Across Key Measures Out To 36 Months From A Phase 1/2 Clinical Trial Evaluating An Investigational Gene Therapy For The Treatment Of CystinosisBenzinga Newsdesk - May 18, 2023, 7:05AM
Thursday, May 11, 2023
- Recap: Avrobio Q1 EarningsBenzinga Insights - May 11, 2023, 8:50AM
- $72.3M In Cash And Cash Equivalents Will Enable Avrobio To Fund Its Operating Expenses And Capital Expenditure Requirements Into Q1 Of 2024; Appointed The Current CFO Erik Ostrowski As Interim CEOBenzinga Newsdesk - May 11, 2023, 7:10AM
- Avrobio Q1 EPS $(0.57) Misses $(0.55) EstimateBenzinga Newsdesk - May 11, 2023, 7:10AM
Monday, May 01, 2023
Friday, March 24, 2023
Thursday, March 23, 2023
Thursday, February 23, 2023
Wednesday, February 08, 2023
- AVROBIO shares are trading higher following a Street Insider report suggesting the company is exploring a potential sale.Bill Haddad - Feb 8, 2023, 1:07PM
- AVROBIO Shares Resume Trade Following Circuit Breaker Halt, Stock Now Up 79.9%Happy Mohamed - Feb 8, 2023, 12:52PM
- AVROBIO Shares Halted On Circuit Breaker To The Upside, Stock Now Up 22.6%Happy Mohamed - Feb 8, 2023, 12:51PM
- 'AVROBIO (AVRO) exploring potential sale after Novartis interest' -Street Insider, Citing SourcesBill Haddad - Feb 8, 2023, 12:44PM
Tuesday, January 10, 2023
Thursday, December 08, 2022
Wednesday, December 07, 2022
- Avrobio Touts New Positive Data From Gaucher Disease Gene TherapyVandana Singh - Dec 7, 2022, 10:10AM
- AVROBIO Announces Clinical Data For Gaucher Disease Gene Therapy; Says 'Following positive feedback from FDA and MHRA, registrational, global Phase 2/3 clinical trial for GD3 planned for second half 2023'Bill Haddad - Dec 7, 2022, 7:33AM